These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28220881)

  • 41. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective serotonin reuptake inhibitors and malformations: case closed?
    Koren G; Nordeng HM
    Semin Fetal Neonatal Med; 2013 Feb; 18(1):19-22. PubMed ID: 23228547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are SSRIs safe for pregnant and breastfeeding women?
    Misri S; Burgmann A; Kostaras D
    Can Fam Physician; 2000 Mar; 46():626-8, 631-3. PubMed ID: 10752001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
    Fan H; Gilbert R; O'Callaghan F; Li L
    BMJ; 2020 Feb; 368():m331. PubMed ID: 32075790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.
    Einarson TR; Einarson A
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):823-7. PubMed ID: 15742359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
    Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
    N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
    Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
    J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter to Editor. Use of specific SSRIs and birth defects.
    Bałkowiec-Iskra E
    Psychiatr Pol; 2015; 49(5):1113-6. PubMed ID: 26688857
    [No Abstract]   [Full Text] [Related]  

  • 50. Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
    Einarson A; Koren G
    Can Fam Physician; 2006 May; 52(5):593-4. PubMed ID: 16739830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.
    Petersen I; Evans SJ; Gilbert R; Marston L; Nazareth I
    J Clin Psychiatry; 2016 Jan; 77(1):e36-42. PubMed ID: 26845280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
    Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
    BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
    De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
    Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Birth outcomes in pregnant women taking fluoxetine.
    Johnson GL
    J Fam Pract; 1997 Jan; 44(1):32. PubMed ID: 9010368
    [No Abstract]   [Full Text] [Related]  

  • 56. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H
    Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.
    Bellantuono C; Migliarese G; Gentile S
    Hum Psychopharmacol; 2007 Apr; 22(3):121-8. PubMed ID: 17397101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
    Wurst KE; Poole C; Ephross SA; Olshan AF
    Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):159-70. PubMed ID: 19739149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age.
    Zhao X; Liu Q; Cao S; Pang J; Zhang H; Feng T; Deng Y; Yao J; Li H
    J Affect Disord; 2018 Dec; 241():563-570. PubMed ID: 30153640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.